About Lamed
Lamed is a company based in Oberhaching (Germany) founded in 1989 by Lazaros Ayvatoglou was acquired by Translumina in June 2023. Lamed offers products and services including Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse. Lamed operates in a competitive market with competitors including TISSIUM, Aziyo Biologics, Cardival Medical, Laminate Medical and Vivasure Medical, among others.
- Headquarter Oberhaching, Germany
- Founders Lazaros Ayvatoglou
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Translumina
(Jun 07, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lamed
Lamed offers a comprehensive portfolio of products and services, including Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse.
System for treating thoracic aortic dissections and aneurysms via endovascular methods.
Acellular patch used in vascular surgery for tissue reinforcement.
Steerable sheath for precise occluder placement in procedures.
Introduction sheath optimized for endovascular access in surgeries.
Funding Insights of Lamed
Detailed funding history for Lamed
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Lamed
Lamed has secured backing from 1 investor. Prominent investors backing the company include Translumina.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of drug-eluting stents and cardiovascular devices. It produces drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories. The company operates advanced manufacturing facilities and is committed to delivering high-quality products. Its focus is on developing and providing innovative cardiovascular intervention technologies. The manufacturing processes adhere to rigorous international standards.
|
Locked | Locked | Locked |
Investor details for Lamed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lamed
Investment portfolio details for Lamed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lamed
Detailed financials for Lamed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lamed Comparisons
Peer comparison for Lamed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lamed
Lamed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Aziyo Biologics, Cardival Medical, Laminate Medical and Vivasure Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
A device for vascular access management is developed.
|
|
| Locked | Locked | Locked |
AV fistula maturation and patency are supported by VasQ device.
|
|
| Locked | Locked | Locked |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| Locked | Locked | Locked |
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
|
Detailed competitors of Lamed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lamed
Complete news archive for Lamed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lamed
Lamed was founded in 1989.
Lamed is headquartered in Oberhaching, Germany. It is registered at Oberhaching, Bavaria, Germany.
The company was founded in 1989 and is based in Oberhaching, Germany. Endovascular solutions are developed for thoracic aortic dissections, aneurysms, and related conditions. Products such as the Ankura TAA stent graft system and the Peri-guard repair patch are included in the portfolio. Operations focus on medical device innovation within the cardiovascular sector, with distribution across Europe.
Lamed's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Lamed offers Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse.
Lamed has 1 investor. Key investors include Translumina.